AKHAN, S. Et Al. 2017. Hepatitis B surface antigen loss and 8 years clinical outcomes with entecavir therapy in Kocaeli.. 20th European Society for Clinical Virology (ESCV) 2017 , (Italy).

AKHAN, S., SAYAN, M., GÜNEŞ, V. E., & AKANSEL, G., (2017). Hepatitis B surface antigen loss and 8 years clinical outcomes with entecavir therapy in Kocaeli. . 20th European Society for Clinical Virology (ESCV) 2017, Italy

AKHAN, SILA Et Al. "Hepatitis B surface antigen loss and 8 years clinical outcomes with entecavir therapy in Kocaeli.," 20th European Society for Clinical Virology (ESCV) 2017, Italy, 2017

AKHAN, SILA Et Al. "Hepatitis B surface antigen loss and 8 years clinical outcomes with entecavir therapy in Kocaeli.." 20th European Society for Clinical Virology (ESCV) 2017 , Italy, 2017

AKHAN, S. Et Al. (2017) . "Hepatitis B surface antigen loss and 8 years clinical outcomes with entecavir therapy in Kocaeli.." 20th European Society for Clinical Virology (ESCV) 2017 , Italy.

@conferencepaper{conferencepaper, author={SILA AKHAN Et Al. }, title={Hepatitis B surface antigen loss and 8 years clinical outcomes with entecavir therapy in Kocaeli.}, congress name={20th European Society for Clinical Virology (ESCV) 2017}, city={}, country={Italy}, year={2017}}